A federal jury in California said on Friday that Apple owes medical-monitoring technology company Masimo $634 million for ...
MedPage Today on MSN
Case Study: Encouraging Treatment for Patient With Advanced HR+/HER2- Breast Cancer With Visceral Crisis
Endocrine therapy is generally recommended for patients with HR+/HER2-metastatic breast cancer, with the exception of those ...
The FDA has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback